Atherosclerosis is not a risk factor for antiplatelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery

Adam Cuker; Lubica Rauova; Douglas Bolgiano; William H. Matthai Jr.; Mortimer Poncz; Barbara A. Konkle

doi:10.1160/TH13-12-1012

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2014; 111(06): 1191-1193
DOI: 10.1160/TH13-12-1012

Letters to the Editor

Schattauer GmbH

Atherosclerosis is not a risk factor for antiplatelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery

Authors

Adam Cuker

¹Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

²Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Lubica Rauova

³Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

⁴Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Douglas Bolgiano

⁵Puget Sound Blood Center, Seattle, Washington, USA
William H. Matthai Jr.

¹Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Mortimer Poncz

³Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

⁴Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Barbara A. Konkle

⁵Puget Sound Blood Center, Seattle, Washington, USA

⁶University of Washington School of Medicine, Seattle, Washington, USA

Abstract

Full Text

References

References
1 Amiral J, Bridey F, Dreyfus M. et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68: 95-96.
2 Pouplard C, May MA, Regina S. et al. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparindependent antibodies. Br J Haematol 2005; 128: 837-841.
3 Gluckman TJ, Segal JB, Schulman SP. et al. Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery. J Thromb Haemost 2009; 07: 1457-1464.
4 Selleng S, Malowsky B, Strobel U. et al. Early-onset and persisting thrombocytopenia in postcardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost 2010; 08: 30-36.
5 Kuitunen A, Suojaranta-Ylinen R, Raivio P. et al. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome. J Cardiothorac Vasc Anesth 2007; 21: 18-22.
6 Bauer TL, Arepally G, Konkle BA. et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997; 95: 1242-1246.
7 Everett BM, Yeh R, Foo SY. et al. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg 2007; 83: 592-597.
8 Warkentin TE, Sheppard JA, Moore JC. et al. Studies of the immune response in heparin-induced thrombocytopenia. Blood 2009; 113: 4963-4969.
9 Krauel K, Weber C, Brandt S. et al. Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes. Blood 2012; 120: 3342-3352.
10 Pitsilos S, Hunt J, Mohler ER. et al. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost 2003; 90: 1112-1120.
11 Mullen MP, Wessel DL, Thomas KC. et al. The incidence and implications of anti-heparin platelet factor 4 antibody formation in a pediatric cardiac surgical population. Anesth Analg 2008; 107: 371-378.